Angle (AGL)

Sector:

Support

Index:

FTSE AIM All-Share

11.00p
   
  • Change Today:
    -0.50p
  • 52 Week High: 31.35p
  • 52 Week Low: 7.25p
  • Currency: UK Pounds
  • Shares Issued: 322.64m
  • Volume: 1,104,485
  • Market Cap: £35.49m
  • RiskGrade: 312
  • Beta: 0.79

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest ShareCast News

Angle signs new agreement US biotech Recursion

By Benjamin Chiou

Date: Thursday 19 Sep 2024

(Sharecast News) - Angle's share price received a boost on Thursday after the liquid biopsy company announced a new agreement with Utah-based biotech firm Recursion Pharmaceuticals.

Angle unveils plans to raise more than £10m

By Abigail Townsend

Date: Wednesday 05 Jun 2024

(Sharecast News) - Liquid biopsy specialist Angle is to raise more than £10m to support future growth, the UK company announced on Wednesday.

Angle reports promising results from Parsortix study

By Benjamin Chiou

Date: Thursday 16 May 2024

(Sharecast News) - Angle, the AIM-listed liquid biopsy company which specialises in circulating tumour cell (CTC) solutions, has announced the results of a clinical study which show that its Parsortix system could be used to predict progression-free survival in patients with ovarian cancer.

Angle strikes supplier deal with AstraZeneca 03-May-2024 ShareCast
Angle granted European patent for CellKeep, US p... 22-Apr-2024 ShareCast
Angle receives 'breakthrough results' from DNA m... 04-Jan-2024 ShareCast
Angle locks in $250,000 contract with Eisai 02-Jan-2024 ShareCast
Angle losses widen in 'breakthrough year' 21-Apr-2023 ShareCast
Tougher market conditions impacting Angle clients 05-Jan-2023 ShareCast
Director dealings: Angle CEO, finance chief join... 19-Jul-2022 ShareCast
Angle wins additional contract with large-scale ... 22-Jun-2022 ShareCast
Angle's Parsortix to be used in 'significant' pr... 20-May-2022 ShareCast
Angle agrees pharma services contract with new c... 28-Jul-2021 ShareCast
Angle completes patient enrolment for ovarian ca... 26-Apr-2021 ShareCast
Angle secures first large-scale pharma services ... 16-Apr-2021 ShareCast
Angle completes clinical labs in Guildford and P... 30-Mar-2021 ShareCast
Angle looks to raise up £20.0m via conditional p... 27-Oct-2020 ShareCast
FDA accepts Angle's review submission for Parsor... 20-Oct-2020 ShareCast
Angle's Parsortix displays potential use for det... 14-Aug-2020 ShareCast
Angle's 'Parsortix' advantageous in breast cance... 20-Jul-2020 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Angle Market Data

Currency UK Pounds
Share Price 11.00p
Change Today -0.50p
% Change -4.35 %
52 Week High 31.35p
52 Week Low 7.25p
Volume 1,104,485
Shares Issued 322.64m
Market Cap £35.49m
Beta 0.79
RiskGrade 312

Angle Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
44.32% below the market average44.32% below the market average44.32% below the market average44.32% below the market average44.32% below the market average
1.12% above the sector average1.12% above the sector average1.12% above the sector average1.12% above the sector average1.12% above the sector average
Price Trend
50.48% below the market average50.48% below the market average50.48% below the market average50.48% below the market average50.48% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Income Not Available
Growth
56.84% above the market average56.84% above the market average56.84% above the market average56.84% above the market average56.84% above the market average
50.54% above the sector average50.54% above the sector average50.54% above the sector average50.54% above the sector average50.54% above the sector average

Angle Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
17:05 158,846 @ 11.00p
15:08 1,844 @ 10.73p
15:05 87,930 @ 10.73p
13:34 4,700 @ 10.73p
13:28 50,000 @ 10.89p

Angle Key Personnel

CEO Andrew D Newland
Finance Director Ian F Griffiths
Chair Jan Groen

Top of Page